These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4987191)

  • 61. Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
    Canafax DM; Savik SK; Draxler CA; Le CT; Ascher NL; Payne WD; Sutherland DE; Migliori RJ; Simmons RL; Najarian JS
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1947-8. PubMed ID: 3274455
    [No Abstract]   [Full Text] [Related]  

  • 62. [Renal homotransplantation in men. Results achieved in 37 patients 26 of whom had received antilymphocyte globulins].
    Küss R; Legrain M; Le Gall JR; Guédon J; Poisson J
    J Urol Nephrol (Paris); 1969 Sep; 75(9):594-600. PubMed ID: 4103960
    [No Abstract]   [Full Text] [Related]  

  • 63. The mixed leukocyte response in human renal transplantation.
    Shons AR; Etheredge EE; Schmidtke JR; Najarian JS
    Transplant Proc; 1973 Mar; 5(1):337-42. PubMed ID: 4266657
    [No Abstract]   [Full Text] [Related]  

  • 64. Hepatitis affecting hemodialysis and transplant patients. Its considerations and consequences.
    Briggs WA; Lazarus JM; Birtch AG; Hampers CL; Hager EB; Merrill JP
    Arch Intern Med; 1973 Jul; 132(1):21-8. PubMed ID: 4577389
    [No Abstract]   [Full Text] [Related]  

  • 65. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
    Cole E; Robinson C; Bear R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
    [No Abstract]   [Full Text] [Related]  

  • 66. Disseminated toxoplasmosis in a liver transplant patient.
    Anthony CW
    J Am Med Womens Assoc (1972); 1972 Nov; 27(11):601-3. PubMed ID: 4342810
    [No Abstract]   [Full Text] [Related]  

  • 67. Metabolic effects of hepatic replacement in Wilson's disease.
    Groth CG; Dubois RS; Corman J; Gustafsson A; Iwatsuki S; Rodgerson DO; Halgrimson CG; Starzl TE
    Transplant Proc; 1973 Mar; 5(1):829-33. PubMed ID: 4572145
    [No Abstract]   [Full Text] [Related]  

  • 68. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
    Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
    [No Abstract]   [Full Text] [Related]  

  • 69. Clinical use of rabbit antihuman lymphocyte globulin in cadaver-kidney transplantation.
    Mannick JA; Davis RC; Cooperband SR; Glasgow AH; Williams LF; Harrington JT; Cavallo T; Schmitt GW; Idelson BA; Olsson CA; Nabseth DC
    N Engl J Med; 1971 May; 284(20):1109-15. PubMed ID: 4928659
    [No Abstract]   [Full Text] [Related]  

  • 70. [Immunosuppressive treatment in renal homologous transplantation].
    Mazzei D; Vallino F; Civardi F
    Minerva Chir; 1975 Aug 15-31; 30(15-16):866-73. PubMed ID: 772470
    [No Abstract]   [Full Text] [Related]  

  • 71. Alternate-day steroids in children after renal transplantation.
    Potter DE; Holliday MA; Wilson CJ; Salvatierra O; Belzer FO
    Transplant Proc; 1975 Mar; 7(1):79-82. PubMed ID: 47201
    [No Abstract]   [Full Text] [Related]  

  • 72. Cyclosporin A (CsA) and azathioprine (Aza) overlap in renal allografts with impaired renal function.
    Castelao AM; Griñó JM; Sabaté I; Gilvernet S; Andres E; Sabater R; Alsina J
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1540-1. PubMed ID: 2652497
    [No Abstract]   [Full Text] [Related]  

  • 73. A controlled trial antilymphocyte globulin therapy (ALG) in man.
    Sheil AG; Mears D; Kelly GE; Stewart JH; Johnson JR; Tiller D; Gallery ED; Duggin GG
    Transplant Proc; 1972 Dec; 4(4):501-5. PubMed ID: 4118965
    [No Abstract]   [Full Text] [Related]  

  • 74. Renal transplantation under cyclophosphamide.
    Starzl TE; Putnam CW; Halgrimson CG; Groth CG; Booth AS; Penn I
    Transplant Proc; 1972 Dec; 4(4):461-4. PubMed ID: 4566786
    [No Abstract]   [Full Text] [Related]  

  • 75. Detection of circulating heart-reactive antibody in human heart transplants.
    Ellis RJ; Lillehei CW; Zabriskie JB
    JAMA; 1970 Mar; 211(9):1505-8. PubMed ID: 4904975
    [No Abstract]   [Full Text] [Related]  

  • 76. Skin allografts and immunosuppression in the treatment of massive thermal injury.
    Koumans RK; Burke JF
    Surgery; 1969 Jul; 66(1):89-96. PubMed ID: 4892315
    [No Abstract]   [Full Text] [Related]  

  • 77. Successful treatment of acute cardiac homograft rejection without antilymphocyte globulin.
    Kauffman HM; Lepley D; Johnson D; Kuban D
    Laval Med; 1970 Feb; 41(2):260-1. PubMed ID: 4102120
    [No Abstract]   [Full Text] [Related]  

  • 78. Specific immunosuppression in cardiac allografting using antithymocyte sera and soluble transplantation antigen.
    Thomas FT; Wolf JS; Thomas JM; Lower RR; Hudson B; Burke S
    Ann Thorac Surg; 1974 Sep; 18(3):241-9. PubMed ID: 4607085
    [No Abstract]   [Full Text] [Related]  

  • 79. [The kidney transplant].
    Montorsi W
    Minerva Med; 1974 Jan; 65(7):321-36. PubMed ID: 4595441
    [No Abstract]   [Full Text] [Related]  

  • 80. Living donor liver transplant for fibrolamellar hepatocellular carcinoma using a deceased donor graft to reconstruct inferior vena cava.
    Slater K; Bak TE; Kam I; Wachs ME
    Liver Transpl; 2004 Apr; 10(4):555-6. PubMed ID: 15048801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.